CJ
Cecilie Johannessen Landmark
OsloMet – Oslo Metropolitan University, Oslo University Hospital
0000-0002-0877-8912
About
Cecilie Johannessen Landmark, PhD, is Professor of Pharmacology and Head of the Pharmacology team at the National Center for Epilepsy. Affiliated to Dept. of Pharmacy, Oslo Metropolitan University and The National Center for Epilepsy and Dept. of Pharmacology, Oslo University Hospital.
Focus on clinical pharmacology of antiseizure medications through research, education and clinical work during the last 20 years and is involved in various national and international collaborations. Research group leader for Medicines and Patient Safety at OsloMet.
Employment
-
OsloMet – Oslo Metropolitan University Professor of Pharmacology2002 - Present
-
Oslo University Hospital Professor / medical adviser
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (125)
- Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development Save
- Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development Save
- Pharmacokinetic variability and complex two‐way interactions with cenobamate in patients with refractory epilepsy Save
- Availability and affordability of cannabinoids for epilepsy treatment across different geographic settings—A survey from the ILAE Plant‐Based Therapy Task Force Save
- Folate transfer across the placenta during late pregnancy in women with epilepsy: A cross‐sectional, two‐center study Save
- Rescue epilepsy medication and training: A comparison between midazolam use, guidelines, clinical practice, and possibilities in the UK and Norway Save
- A precision approach to therapeutic drug monitoring of valproate to evaluate markers of toxicity Save
- Pharmacokinetic variability and use of therapeutic drug monitoring of cannabidiol in patients with refractory epilepsy Save
- Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy Save
- Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real‐world study Save